Gryphon Investors has sponsored simultaneous recapitalizations of Carlsbad, Calif.-based Synteract Inc. and Overland Park, Kan.-based Vince & Associates Clinical Research, providers of outsourced pharma services to biotech and drug companies. No financial terms were disclosed. Celerity Partners, an existing backer of both companies, will remain a shareholder.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .-
Sign in or Register
-
Issues with signing in? Click here
Don't have an account? Register now
-
